VTGN: VistaGen Therapeutics Inc

VTGN新闻

• 22:52 Vistagen Therapeutics公司的fasedienol三期临床试验未达终点
• 22:51 Vistagen Therapeutics reports Phase 3 trial for fasedienol did not meet endpoint
• 21:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%
• 21:30 美国股市收低；截至收盘道琼斯工业平均指数下跌0.47%
• 20:12 Jefferies下调VistaGen股票评级至持有，因第三期临床试验失败
• 20:11 Jefferies downgrades VistaGen stock rating to Hold on failed Phase III trial
• 17:51 William Blair将VistaGen股票评级下调，原因是临床试验未达预期
• 17:49 VistaGen stock rating downgraded by William Blair after trial miss
• 16:28 Stifel将VistaGen股票评级下调至"持有"，因焦虑药物在试验中失败
• 16:27 Stifel downgrades VistaGen stock to Hold as anxiety drug fails in trial
• 14:37 Vistagen股价因焦虑治疗试验失败而暴跌
• 14:32 Vistagen stock plummets after failed anxiety treatment trial
• 13:42 Vistagen的焦虑症治疗在临床试验中未达主要终点
• 13:38 Vistagen’s anxiety treatment fails to meet primary endpoint in trial
• 12:42 Vistagen's Social Anxiety Disorder Drug Disappoints In Pivotal Late-Stage Study - Vistagen Therapeutics (NASDAQ:VTGN)
• 12:02 Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)
• 09:39 Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)
• 13:54 Vistagen任命Nick Tressler为新首席财务官
• 13:37 Vistagen公布PH80治疗更年期潮热的数据
• 13:34 Vistagen presents data on PH80 for menopausal hot flashes treatment